SAMANTHA VERGARA: Open Payments
NPI 1033887021 · DECATUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 35 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $93 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $326 |
| Regeneron Healthcare Solutions, Inc. | 6 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $146 |
| Phathom Pharmaceuticals, Inc. | 2 | $128 |
| Madrigal Pharmaceuticals | 1 | $92 |
| QOL Medical, LLC | 3 | $66 |
| Ardelyx, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $58 |
| Kerecis Limited | 1 | $54 |
| ConvaTec Inc. | 1 | $28 |
Products named: DUPIXENT, VOQUEZNA, REZDIFFRA, ENTYVIO, EOHILIA, Sucraid, IBSRELA, LINZESS.
Industry payments across IN — which companies pay providers there.
